Effect of cytokine mobilization regimen on graft-versus-host disease (GVHD)/survival.
| . | G-CSF, % n = 40 . | G-CSF and GM-CSF, % n = 66 . | GM-CSF, % n = 30 . | P Value . |
|---|---|---|---|---|
| Abbreviations: G-CSF, granulocyte colony-stimulating factor; GM-CSF, granulocyte-macrophage colony-stimulating factor; NS, not significant | ||||
| Acute grade 2–4 | 51 | 65 | 13 | G vs GM: .003 |
| GM vs G/GM: < .0001 | ||||
| G vs G/GM: .11 | ||||
| Acute grade 3–4 | 11 | 13 | 0 | .07 |
| Chronic GVHD | 86 | 88 | 65 | NS |
| Survival (2 years) | 62 | 56 | 59 | NS |
| * High 38 | High 28 | High 35 | ||
| * Low 88 | Low 75 | Low 69 | ||
| . | G-CSF, % n = 40 . | G-CSF and GM-CSF, % n = 66 . | GM-CSF, % n = 30 . | P Value . |
|---|---|---|---|---|
| Abbreviations: G-CSF, granulocyte colony-stimulating factor; GM-CSF, granulocyte-macrophage colony-stimulating factor; NS, not significant | ||||
| Acute grade 2–4 | 51 | 65 | 13 | G vs GM: .003 |
| GM vs G/GM: < .0001 | ||||
| G vs G/GM: .11 | ||||
| Acute grade 3–4 | 11 | 13 | 0 | .07 |
| Chronic GVHD | 86 | 88 | 65 | NS |
| Survival (2 years) | 62 | 56 | 59 | NS |
| * High 38 | High 28 | High 35 | ||
| * Low 88 | Low 75 | Low 69 | ||